More specifically, germline BRCA1/BRCA2 alterations have been associated with a higher Gleason score, metastases at diagnosis, rates of overall survival, and metastasis-free survival in PCa [37] as well as response to treatment [32]. The gene discussed is BRCA2; the disease is posterior cortical atrophy.